Portfolio Holdings Detail for ISIN IE00B6R52259
| Stock Name / Fund | iShares MSCI ACWI UCITS ETF |
| Issuer | Blackrock |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | IUSQ(EUR) F |
| ETF Ticker | ISAC.LS(USD) CXE |
| ETF Ticker | IUSQ.DE(EUR) CXE |
| ETF Ticker | SSAC.AS(EUR) CXE |
| ETF Ticker | SSAC.LS(GBX) CXE |
| ETF Ticker | SSACz(USD) CXE |
| ETF Ticker | SSAC(EUR) Euronext Amsterdam |
| ETF Ticker | ISAC(EUR) ETF Plus |
Holdings detail for EW
| Stock Name | Edwards Lifesciences Corp |
| Ticker | EW(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US28176E1082 |
| LEI | YA13X31F3V31L8TMPR58 |
Show aggregate EW holdings
News associated with EW
- Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
- Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
- Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
- Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
- Top Stock Reports for Apple, Novartis & Charles Schwab
- Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
- Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
- Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
- Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
- Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
- Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
- Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
- Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
- Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
- Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
- Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
- Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
- Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
- Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
- Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
- Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
- Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
- Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
- Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
- Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
- Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
- Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
- Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
- S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
- The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
- Solid Corporate Earnings Results Support Stocks
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
- Solid Corporate Earnings Results Support Stocks
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
- Positive Earnings Results Lift Stocks
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
- Solid Corporate Earnings Results Support Stocks
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
- Positive Earnings Results Lift Stocks
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
- J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
- J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
- Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
- Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
- Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
- Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
- Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
- Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07
iShares MSCI ACWI UCITS ETF EW holdings
| Date | Number of EW Shares Held | Base Market Value of EW Shares | Local Market Value of EW Shares | Change in EW Shares Held | Change in EW Base Value | Current Price per EW Share Held | Previous Price per EW Share Held |
|---|
| 2026-02-09 (Monday) | 177,941 | USD 13,665,869 | USD 13,665,869 | | | | |
| 2026-02-06 (Friday) | 177,941 | USD 14,005,736 | USD 14,005,736 | | | | |
| 2026-01-30 (Friday) | 176,501 | USD 14,360,121 | USD 14,360,121 | 2,160 | USD -331,595 | USD 81.36 | USD 84.27 |
| 2026-01-26 (Monday) | 174,341 | USD 14,691,716 | USD 14,691,716 | 0 | USD 106,348 | USD 84.27 | USD 83.66 |
| 2026-01-23 (Friday) | 174,341 | USD 14,585,368 | USD 14,585,368 | 0 | USD -258,025 | USD 83.66 | USD 85.14 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of EW by Blackrock for IE00B6R52259
Show aggregate share trades of EW| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2026-01-30 | BUY | 2,160 | 82.820 | 80.750 | 80.957 | USD 174,867 | - |
| 2026-01-20 | BUY | 360 | 85.160 | 82.820 | 83.054 | USD 29,899 | - |
| 2026-01-07 | BUY | 1,350 | 86.600 | 83.935 | 84.201 | USD 113,672 | - |
| 2025-12-31 | BUY | 720 | 86.600 | 85.200 | 85.340 | USD 61,445 | - |
| 2025-12-31 | BUY | 720 | 86.600 | 85.200 | 85.340 | USD 61,445 | - |
| 2025-12-29 | BUY | 180 | 87.350 | 86.725 | 86.787 | USD 15,622 | - |
| 2025-12-23 | BUY | 720 | 86.530 | 85.820 | 85.891 | USD 61,842 | - |
| 2025-12-18 | BUY | 270 | 86.070 | 84.650 | 84.792 | USD 22,894 | - |
| 2025-12-16 | BUY | 270 | 85.755 | 82.310 | 82.654 | USD 22,317 | - |
| 2025-12-12 | BUY | 360 | 84.490 | 83.040 | 83.185 | USD 29,947 | - |
| 2025-12-04 | BUY | 1,260 | 85.960 | 83.980 | 84.178 | USD 106,064 | - |
| 2025-11-25 | BUY | 756 | 86.940 | 84.655 | 84.883 | USD 64,172 | - |
| 2025-11-24 | BUY | 360 | 85.435 | 83.810 | 83.972 | USD 30,230 | - |
| 2025-11-11 | BUY | 89 | 85.397 | 84.310 | 84.419 | USD 7,513 | - |
| 2025-11-04 | BUY | 180 | 84.830 | 82.890 | 83.084 | USD 14,955 | - |
| 2025-10-15 | BUY | 450 | 72.930 | 73.830 | 73.740 | USD 33,183 | - |
| 2025-10-08 | BUY | 180 | 75.740 | 75.790 | 75.785 | USD 13,641 | - |
| 2025-09-24 | BUY | 540 | 74.660 | 75.300 | 75.236 | USD 40,627 | - |
| 2025-09-15 | BUY | 810 | 76.050 | 78.100 | 77.895 | USD 63,095 | - |
| 2025-09-09 | BUY | 801 | 79.800 | 80.740 | 80.646 | USD 64,597 | - |
| 2025-09-04 | BUY | 1,068 | 80.960 | 81.570 | 81.509 | USD 87,052 | - |
| 2025-08-28 | BUY | 267 | 81.230 | 81.290 | 81.284 | USD 21,703 | - |
| 2025-08-19 | BUY | 623 | 78.930 | 79.350 | 79.308 | USD 49,409 | - |
| 2025-08-12 | BUY | 1,672 | 76.930 | 78.040 | 77.929 | USD 130,297 | - |
| 2025-08-06 | BUY | 264 | 78.610 | 79.630 | 79.528 | USD 20,995 | - |
| 2025-08-04 | BUY | 352 | 80.090 | 80.110 | 80.108 | USD 28,198 | - |
| 2025-08-01 | BUY | 528 | 79.330 | 79.730 | 79.690 | USD 42,076 | - |
| 2025-07-31 | BUY | 440 | 79.310 | 81.050 | 80.876 | USD 35,585 | - |
| 2025-07-28 | BUY | 267 | 78.490 | 80.730 | 80.506 | USD 21,495 | - |
| 2025-07-25 | BUY | 356 | 80.000 | 83.000 | 82.700 | USD 29,441 | - |
| 2025-07-22 | BUY | 445 | 76.300 | 77.020 | 76.948 | USD 34,242 | - |
| 2025-07-21 | BUY | 178 | 76.560 | 77.570 | 77.469 | USD 13,789 | - |
| 2025-07-14 | BUY | 267 | 78.280 | 78.810 | 78.757 | USD 21,028 | - |
| 2025-07-10 | BUY | 534 | 78.800 | 78.900 | 78.890 | USD 42,127 | - |
| 2025-07-08 | BUY | 267 | 76.390 | 77.300 | 77.209 | USD 20,615 | - |
| 2025-07-02 | BUY | 445 | 77.020 | 78.070 | 77.965 | USD 34,694 | - |
| 2025-06-25 | BUY | 88 | 76.970 | 77.270 | 77.240 | USD 6,797 | - |
| 2025-06-12 | BUY | 792 | 75.890 | 76.620 | 76.547 | USD 60,625 | - |
| 2025-06-02 | BUY | 1,044 | 78.100 | 78.140 | 78.136 | USD 81,574 | - |
| 2025-05-28 | BUY | 264 | 76.660 | 78.750 | 78.541 | USD 20,735 | - |
| 2025-05-14 | BUY | 261 | 76.750 | 77.240 | 77.191 | USD 20,147 | - |
| 2025-05-08 | BUY | 435 | 74.630 | 76.130 | 75.980 | USD 33,051 | - |
| 2025-05-07 | BUY | 1,392 | 75.040 | 75.750 | 75.679 | USD 105,345 | - |
| 2025-04-30 | BUY | 258 | 75.490 | 76.350 | 76.264 | USD 19,676 | - |
| 2025-04-24 | BUY | 87 | 75.130 | 76.290 | 76.174 | USD 6,627 | - |
| 2025-04-23 | BUY | 696 | 70.460 | 72.750 | 72.521 | USD 50,475 | - |
| 2025-04-17 | BUY | 348 | 71.530 | 72.150 | 72.088 | USD 25,087 | - |
| 2025-04-16 | BUY | 174 | 71.200 | 71.910 | 71.839 | USD 12,500 | - |
| 2025-04-15 | BUY | 174 | 70.760 | 70.990 | 70.967 | USD 12,348 | - |
| 2025-04-14 | BUY | 522 | 69.870 | 70.300 | 70.257 | USD 36,674 | - |
| 2025-04-11 | BUY | 1,376 | 69.400 | 69.830 | 69.787 | USD 96,027 | - |
| 2025-04-10 | BUY | 774 | 68.260 | 69.350 | 69.241 | USD 53,593 | - |
| 2025-04-09 | BUY | 430 | 69.900 | 70.500 | 70.440 | USD 30,289 | - |
| 2025-04-08 | BUY | 435 | 67.070 | 70.780 | 70.409 | USD 30,628 | - |
| 2025-04-07 | BUY | 348 | 69.000 | 71.220 | 70.998 | USD 24,707 | - |
| 2025-04-04 | BUY | 435 | 69.360 | 71.720 | 71.484 | USD 31,096 | - |
| 2025-04-02 | BUY | 344 | 72.050 | 72.360 | 72.329 | USD 24,881 | - |
| 2025-03-28 | BUY | 348 | 70.910 | 71.660 | 71.585 | USD 24,912 | - |
| 2025-03-24 | BUY | 174 | 71.350 | 72.240 | 72.151 | USD 12,554 | - |
| 2025-03-18 | BUY | 261 | 70.340 | 71.080 | 71.006 | USD 18,533 | - |
| 2025-03-17 | BUY | 435 | 70.630 | 71.050 | 71.008 | USD 30,888 | - |
| 2025-03-14 | BUY | 348 | 69.290 | 69.660 | 69.623 | USD 24,229 | - |
| 2025-03-13 | BUY | 783 | 67.950 | 68.920 | 68.823 | USD 53,888 | - |
| 2025-03-10 | BUY | 261 | 68.530 | 69.970 | 69.826 | USD 18,225 | - |
| 2025-03-04 | BUY | 344 | 71.380 | 71.690 | 71.659 | USD 24,651 | - |
| 2025-02-26 | BUY | 6,971 | 71.960 | 72.400 | 72.356 | USD 504,394 | - |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of EW
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 406,402 | 0 | 1,881,727 | 21.6% |
| 2025-09-18 | 684,520 | 1,177 | 3,487,981 | 19.6% |
| 2025-09-17 | 484,322 | 210 | 1,603,065 | 30.2% |
| 2025-09-16 | 811,953 | 856 | 2,055,937 | 39.5% |
| 2025-09-15 | 611,012 | 104 | 1,391,882 | 43.9% |
| 2025-09-12 | 982,928 | 1,100 | 2,234,227 | 44.0% |
| 2025-09-11 | 514,234 | 828 | 1,919,009 | 26.8% |
| 2025-09-10 | 669,705 | 149 | 1,567,941 | 42.7% |
| 2025-09-09 | 441,493 | 0 | 925,375 | 47.7% |
| 2025-09-08 | 632,587 | 672 | 1,251,939 | 50.5% |
| 2025-09-05 | 334,037 | 300 | 934,006 | 35.8% |
| 2025-09-04 | 380,318 | 0 | 871,931 | 43.6% |
| 2025-09-03 | 701,943 | 459 | 1,170,966 | 59.9% |
| 2025-09-02 | 397,396 | 53 | 1,208,872 | 32.9% |
| 2025-08-29 | 397,628 | 800 | 844,318 | 47.1% |
| 2025-08-28 | 604,087 | 4 | 1,056,653 | 57.2% |
| 2025-08-27 | 493,608 | 822 | 875,886 | 56.4% |
| 2025-08-26 | 480,268 | 0 | 868,213 | 55.3% |
| 2025-08-25 | 796,556 | 0 | 1,181,258 | 67.4% |
| 2025-08-22 | 552,739 | 1 | 1,011,678 | 54.6% |
| 2025-08-21 | 873,044 | 798 | 1,597,742 | 54.6% |
| 2025-08-20 | 847,847 | 38,699 | 1,560,105 | 54.3% |
| 2025-08-19 | 613,349 | 33 | 1,256,577 | 48.8% |
| 2025-08-18 | 668,719 | 439 | 1,642,759 | 40.7% |
| 2025-08-15 | 369,455 | 513 | 826,723 | 44.7% |
| 2025-08-14 | 514,202 | 6,112 | 864,593 | 59.5% |
| 2025-08-13 | 567,857 | 299 | 1,347,264 | 42.1% |
| 2025-08-12 | 547,773 | 12,316 | 1,428,277 | 38.4% |
| 2025-08-11 | 487,823 | 0 | 1,152,630 | 42.3% |
| 2025-08-08 | 661,697 | 20 | 1,224,458 | 54.0% |
| 2025-08-07 | 669,931 | 982 | 1,297,469 | 51.6% |
| 2025-08-06 | 880,028 | 413 | 1,551,659 | 56.7% |
| 2025-08-05 | 661,933 | 8 | 1,592,649 | 41.6% |
| 2025-08-04 | 572,165 | 268 | 1,310,044 | 43.7% |
| 2025-08-01 | 678,028 | 5,600 | 1,308,863 | 51.8% |
| 2025-07-31 | 831,401 | 249 | 1,817,975 | 45.7% |
| 2025-07-30 | 1,305,016 | 693 | 2,481,808 | 52.6% |
| 2025-07-29 | 1,129,154 | 58 | 2,399,223 | 47.1% |
| 2025-07-28 | 684,101 | 2,111 | 2,276,892 | 30.0% |
| 2025-07-25 | 1,669,752 | 920 | 6,616,259 | 25.2% |
| 2025-07-24 | 455,593 | 0 | 2,607,898 | 17.5% |
| 2025-07-23 | 444,645 | 0 | 1,978,110 | 22.5% |
| 2025-07-22 | 447,883 | 511 | 2,702,925 | 16.6% |
| 2025-07-21 | 568,293 | 27 | 1,249,727 | 45.5% |
| 2025-07-18 | 590,448 | 59 | 2,118,402 | 27.9% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy